GlassScriptPhysician profile
Syed Aarish Hasan
NPI 1235768748
$9,667.10
in general payments reported to CMS, 2019-2025
9 companies · $1,381 in 2025
The $1,381 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,588 · 2022: $1,923 · 2023: $2,750 · 2024: $2,025 · 2025: $1,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,624 · Grant: $1,795 · Food and Beverage: $1,690 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,624.39 |
| Grant | $1,795.00 |
| Food and Beverage | $1,690.22 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,142.30 | 2023-2025 | Oxford, Affixus, Persona |
| Cgg Medical INC | $2,925.54 | 2021-2025 | |
| Stryker Corporation | $1,346.51 | 2022-2025 | Mako, T2 Alpha, Inspace |
| Medtronic, INC. | $634.07 | 2021-2023 | Aquamantys(Tm), Unid_pass |
| Integra Lifesciences Corporation | $230.03 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocomposites INC | $125.81 | 2025 | Stimulan |
| Acelrx Pharmaceuticals, INC. | $120.02 | 2021 | |
| Encore Medical, LP | $98.70 | 2025 | |
| Linvatec Corporation | $44.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.